SCHEMBL6155076

SCHEMBL6155076

CCOc1cc(Cl)c(C(=O)c2ccccc2)cc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.51
MAPT P10636 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM4E B2RXH2 2/20 0.45
TP53 P04637 1/20 0.45
PTGDR2 Q9Y5Y4 1/20 0.45
MAPK1 P28482 2/20 0.43
ABL1 P00519 1/20 0.43
GAA P10253 1/20 0.43
RIN1 Q13671 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL28904294 0.99 LMNA (0.50) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL29022661 0.85 LMNA (0.57) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL5044303 0.85 MAPT (0.50) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL7637797 0.85 HPGD (0.60) LMNAMAPTKMT2ASMN1; SMN2ALDH1A1
SCHEMBL9984540 0.83 TSHR (0.61) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL14248500 0.81 MAPT (0.56) MAPTKMT2ARAB9AALDH1A1HPGD
SCHEMBL4461435 0.80 MAPT (0.43) LMNAMAPTSMN1; SMN2HPGDCYP1A2
SCHEMBL31255615 0.78 MAPT (0.49) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL30033997 0.78 RAB9A (0.67) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL720460 0.78 RAB9A (0.67) LMNAMAPTMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115445242-B Device and method for treating dapagliflozin intermediate mother liquor 浙江工业大学 2024-03-01 CN claimed
CN-115445242-A Treatment device and method for dapagliflozin intermediate mother liquor 浙江工业大学 2022-12-09 CN claimed
CN-107311847-B Preparation method of 5-bromo-2-chloro-4' -ethoxy diphenylmethane 安徽省诚联医药科技有限公司 2020-11-10 CN claimed
CN-111662166-A Preparation method of 5-bromo-2-chloro-4' -ethoxy diphenylmethane 吴赣药业(苏州)有限公司 2020-09-15 CN claimed
CN-115445242-B Device and method for treating dapagliflozin intermediate mother liquor 浙江工业大学 2024-03-01 CN disclosed
CN-115445242-B Device and method for treating dapagliflozin intermediate mother liquor 浙江工业大学 2024-03-01 CN disclosed
CN-116332733-A Synthesis process of dapagliflozin intermediate 江苏阿尔法药业股份有限公司 2023-06-27 CN disclosed
CN-115445242-A Treatment device and method for dapagliflozin intermediate mother liquor 浙江工业大学 2022-12-09 CN disclosed
CN-115445242-A Treatment device and method for dapagliflozin intermediate mother liquor 浙江工业大学 2022-12-09 CN disclosed
CN-107311847-B Preparation method of 5-bromo-2-chloro-4' -ethoxy diphenylmethane 安徽省诚联医药科技有限公司 2020-11-10 CN disclosed
CN-107311847-B Preparation method of 5-bromo-2-chloro-4' -ethoxy diphenylmethane 安徽省诚联医药科技有限公司 2020-11-10 CN disclosed
CN-111662166-A Preparation method of 5-bromo-2-chloro-4' -ethoxy diphenylmethane 吴赣药业(苏州)有限公司 2020-09-15 CN disclosed
CN-111662166-A Preparation method of 5-bromo-2-chloro-4' -ethoxy diphenylmethane 吴赣药业(苏州)有限公司 2020-09-15 CN disclosed
CN-111099975-A Preparation method of 5-bromo-2-chloro-4' -ethoxy benzophenone 河北合佳医药科技集团股份有限公司 2020-05-05 CN disclosed
EP-1506211-A4 C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD BRISTOL MYERS SQUIBB CO (US) 2005-08-17 EP disclosed
EP-1506211-A1 C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD Bristol-Myers Squibb Company (US) 2005-02-16 EP disclosed
WO-2003099836-A1 C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 WO disclosed